Extensions to the Visual Predictive Check to facilitate model performance evaluation
Open Access
- 16 January 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Pharmacokinetics and Pharmacodynamics
- Vol. 35 (2), 185-202
- https://doi.org/10.1007/s10928-007-9081-1
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Population Pharmacokinetics of Humanized Monoclonal Antibody HuCC49ΔCH2 and Murine Antibody CC49 in Colorectal Cancer PatientsThe Journal of Clinical Pharmacology, 2007
- Are Population Pharmacokinetic and/or Pharmacodynamic Models Adequately Evaluated?Clinical Pharmacokinetics, 2007
- Metrics for External Model Evaluation with an Application to the Population Pharmacokinetics of GliclazidePharmaceutical Research, 2006
- A Mechanism-based Disease Progression Model for Comparison of Long-term Effects of Pioglitazone, Metformin and Gliclazide on Disease Processes Underlying Type 2 Diabetes MellitusJournal of Pharmacokinetics and Pharmacodynamics, 2006
- A new equivalence based metric for predictive check to qualify mixed-effects modelsThe AAPS Journal, 2005
- Comparison of Pioglitazone and Gliclazide in Sustaining Glycemic Control Over 2 Years in Patients With Type 2 DiabetesDiabetes Care, 2005
- Multiple Imputation for Model Checking: Completed‐Data Plots with Missing and Latent DataBiometrics, 2005
- Drug Treatment Effects on Disease ProgressionAnnual Review of Pharmacology and Toxicology, 2001
- Pharmacokinetic/Pharmacodynamic Modeling in Drug DevelopmentAnnual Review of Pharmacology and Toxicology, 2000
- Analysis of Nonrandomly Censored Ordered Categorical Longitudinal Data from Analgesic TrialsJournal of the American Statistical Association, 1997